J. Gagneron, G. Gosselin, and C. Mathe´
385
SYNTHESIS
The synthesis of compound 1 was achieved from L-xylose in 3 steps using a
procedure previously established for D-xylose.[2] The cyclopropanation of
compound 2 was accomplished via a Simmons-Smith reaction following
Furukawa’s procedure[3] to afford a mixture of compounds 3a and 3b (ratio 3a/
3b: 98/2). Separation of compounds 3a and 3b was readily achieved on silica gel
column chromatography. Structural assignments of 3a and 3b were based upon 1H
NMR spectra and NOE effects. After cleavage of the isopropylidene group, an
oxidation-reduction process gave stereospecifically compound 5, which was finally
converted into the sugar precursor 6, obtained as a mixture of b- and a-anomers
(ratio a/b: 9/91) with an 20% overall yield from L-xylose (Scheme 1).
Coupling reactions of sugar 6 with silylated bases (uracil, thymine, and
cytosine) provided acetylated nucleosides 7--9 (Scheme 2). The deprotection of
7--9 afforded the target restricted 3’-deoxy-3’,4’-exo-methylene pyrimidine nucleo-
side analogues 10--12.
Structural assignments for all the compounds were based upon their elemental
1
analysis and physicochemical properties (melting point, H NMR, 13C NMR, UV,
mass spectra, and optical rotation).
CONFORMATIONAL ANALYSIS
We used the program Pseurot[4] for the determination of the conformation of
the furanose ring taking compound 11 as a model. After determination of
parameters A and B using FHH = Anj + B, a convergence was obtained toward a
south-type conformation with P = 158° and nmax = 23.9° (x [south = 0.69]) and
north-type conformation with P = À26.5° and nmax = 21.6°.
BIOLOGICAL EVALUATIONS
The nucleoside analogues 10--12 were tested for their in vitro inhibitory
effects on the replication of HIV, HBV, and several RNA viruses. None of these
compounds showed significant antiviral activity.
REFERENCES
1. Choi, Y.; Moon, H.R.; Yoshimura, Y.; Marquez, V.E. Recent advances in the synthesis of conformationally
locked nucleosides and their success in probing the critical question of conformational preferences by their
biological targets. Nucleosides Nucleotides Nucleic Acids 2003, 22(5--8), 547–557.
2. Ichikawa, E.; Kato, K. Sugar-modified nucleosides in past 10 years, a review. Curr. Med. Chem. 2001, 8,
385–423.
3. Lebel, H.; Marcoux, J.F.; Molinaro, C.; Charette, A.B. Stereoselective cyclopropanation reactions. Chem. Rev.
2003, 103(4), 977–1050.
4. Houseknecht, J.B.; Altona, C.; Hadad, C.M.; Lowary, T.L. Conformational analysis of furanose rings with
PSEUROT: parametrization for rings possessing the arabino, lyxo, ribo, and xylo stereochemistry and
application to arabinofuranosides. J. Org. Chem. 2002, 67(14), 4647–4651.